Artificial expression of PD‐L1 or administration of PD‐L1.Fc in vivo has shown protective effects against T‐cell–mediated pathology in models of type 1 diabetes, colitis, liver sepsis and nephritis.14, 39, 40, 41. This evidence concerns the gene CD274 and colitis.